KEVIN CHARLES GORMAN Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN CHARLES GORMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of KEVIN CHARLES GORMAN for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 32.99 | 3,031 | 99,993 | 0 | |
| Aug 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 32.99 | 3,031 | 99,993 | 420,628 | 417.6 K to 420.6 K (+0.73 %) |
| Aug 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 32.99 | 3,031 | 99,993 | 0 | |
| Aug 13 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 32.99 | 3,031 | 99,993 | 420,628 | 417.6 K to 420.6 K (+0.73 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.66 | 26,330 | 228,018 | 143,449 | |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.66 | 2,759 | 23,893 | 169,779 | |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Option Exercise | M | 8.66 | 50,911 | 440,889 | 172,538 | |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Sell | S | 95.64 | 26,330 | 2,518,154 | 417,597 | 443.9 K to 417.6 K (-5.93 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.66 | 26,330 | 228,018 | 443,927 | 417.6 K to 443.9 K (+6.31 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Sell | S | 95.12 | 2,759 | 262,440 | 417,597 | 420.4 K to 417.6 K (-0.66 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.66 | 2,759 | 23,893 | 420,356 | 417.6 K to 420.4 K (+0.66 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Sell | S | 95.15 | 50,911 | 4,844,380 | 417,597 | 468.5 K to 417.6 K (-10.87 %) |
| Aug 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | GORMAN KEVIN CHARLES | Chief Executive Off ... | Buy | M | 8.66 | 50,911 | 440,889 | 468,508 | 417.6 K to 468.5 K (+12.19 %) |